In the framework of Joint Arab action and in order to encourage the pharmaceutical industry, the Economic Unity Arab Council has adopted a decision on 6/3/1976 to establish an Arab institution that is capable of promoting this industry, which is the Arab Company for Drug Industries and Medical Appliances "ACDIMA", with a capital of (60) million Kuwaiti Dinars, that has been raised by the approval of the Extraordinary General Assembly held in Amman - Jordan on 10/10/2013 to (90) million Kuwaiti Dinars according to Riyadh Declaration for 2013, which approved the increase of the capital of joint Arab companies by at least 50%..
Acdima Company was established in 1976, at a time when the pharmaceutical industry in the Arab world was either in its infancy in some countries or non-existent in others. Now, after 46 years since the company's establishment, the pharmaceutical industry has developed in the majority of Arab countries, either with Acdima's support or through self-investment. It is worth mentioning that the world is witnessing radical changes in the management of businesses in both government and private institutions to enhance their performance, ensuring the sustainability of these institutions.
In this context, the Board of Directors aims, during its current term, to finalize the development of a new vision supported by an effective strategic plan to achieve economic growth and a rewarding profit return for the company. One of the key pillars of the plan will be the restructuring of the company's current operations, which will be based on sound governance and investment standards that align with global developments and ensure appropriate growth in shareholder equity and the sustainability of the company's operations.
In conclusion, I would like to express my sincere thanks and appreciation to our valued shareholders and Board Members for their support, and my gratitude to Acdima's employees for their efforts in maintaining the company's operations. I also thank the affiliated companies and all their staff, as well as the concerned parties, for their trust, ongoing support, and sincere efforts in the success of this leading Arab institution.
Khaled AlRabiah
Chairman of the Board
As part of Arab joint action to encourage the pharmaceutical industry, the Arab Economic Unity Council made a decision to establish an Arab institution capable of fulfilling this mission
The Arab Company for Pharmaceutical Industries and Medical Supplies, "ACDIMA," was established on March 6, 1976, with an initial capital of 60 million Kuwaiti Dinars.
An increase in the capital of joint Arab companies by at least 50% was approved according to the Riyadh Declaration of 2013, and the paid-up capital amounts to 83,930,000 Kuwaiti Dinars
Ensuring optimal returns from investments that drive growth in the pharmaceutical industry sector in the Arab World
ACDIMA has increased its shares in many important companies.
The capital has been increased by 50% to reach 90 million.
ACDIMA owns 25% from CAD company
ACDIMA Center for Bioequivalence and Pharmaceutical Studies was established
ACDIMA for Veterinary Medicines Industries “ACDIVET” was established, ACDIMA owns 100 %
ACDIMA owns 64.14 % from Saiph Company
ACDIMA owns 20% from Spimaco Addawaeih's company
ACDIMA owns 9% from Julphar's Company
ACDIMA owns 34.06 % from ACAI's company
ِACDIMA has contributed to many important companies in the Arab world
A Pan-Arab shareholding company established by a resolution from the Arab Economic Unity Council on March 6, 1976, Authorized Capital is: Kuwaiti Dinar (90) million.